BRIDGEBIO PHARMA INC

CUSIP: 10806XAB8 Class: NOTE 2.500% 3/1

WELLS FARGO & COMPANY/MN's Holding History (CIK: 0000072971)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 371,000 Value ($000) $701 Avg Close — Range —
Q3 2025
Shares 1,000 Value ($000) $1 Avg Close — Range —
Q2 2025
Shares 1,657,000 Value ($000) $2,064 Avg Close — Range —
Q1 2025
Shares 1,697,000 Value ($000) $1,942 Avg Close — Range —
Q4 2024
Shares 2,309,000 Value ($000) $2,425 Avg Close — Range —
Q3 2024
Shares 13,543,000 Value ($000) $13,968 Avg Close — Range —
Q2 2024
Shares 15,226,000 Value ($000) $15,062 Avg Close — Range —
Q1 2024
Shares 14,933,000 Value ($000) $16,065 Avg Close — Range —
Q4 2023
Shares 17,181,000 Value ($000) $20,758 Avg Close — Range —
Q3 2023
Shares 18,640,000 Value ($000) $17,928 Avg Close — Range —
Q2 2023
Shares 15,957,000 Value ($000) $12,516 Avg Close — Range —
Q1 2023
Shares 13,757,000 Value ($000) $10,283 Avg Close — Range —
Q4 2022
Shares 12,157,000 Value ($000) $4,832 Avg Close — Range —
Q3 2022
Shares 12,157,000 Value ($000) $7,149 Avg Close — Range —
Q2 2022
Shares 12,157,000 Value ($000) $5,470 Avg Close — Range —
Q1 2022
Shares 13,157,000 Value ($000) $7,733 Avg Close — Range —
Q4 2021
Shares 14,656,000 Value ($000) $10,681 Avg Close — Range —
Q3 2021
Shares 7,156,000 Value ($000) $9,897 Avg Close — Range —
Q2 2021
Shares 15,156,000 Value ($000) $24,785 Avg Close — Range —
Q1 2021
Shares 8,845,000 Value ($000) $14,685 Avg Close — Range —